Radical-catalyzed cycloaddition produces high-yield bioisostere in diverse substrates, indicating synthetic versatility.
The development of Fsp3-rich bioisosteres for meta-substituted benzenes remains a significant challenge in medicinal chemistry. We herein disclose novel redox-active N-heterocyclic selone (NHS) catalysts that enable a radical-catalyzed [2σ + 2π] cycloaddition platform, providing direct access to 1,3-bicyclohexane, a geometrically congruent bioisostere for meta-substituted benzene. This method enables efficient radical-mediated cycloaddition of vinyl-bicyclobutanes (V-BCBs) with diverse alkenes, achieving high yields (up to 99%) and broad substrate compatibility (47 examples) with a low catalyst loading (1 mol %). Mechanistic studies and DFT calculations confirm the generation of the NHC-stabilized selenium-centered radical (C6·+) via a radical buffer strategy under blue-light irradiation. Downstream manipulation and the expedient synthesis of an Fsp3-rich analogue of the anticancer drug Sonidegib substantiate the synthetic versatility of our catalytic platform.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: